1. Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study. (1st June 2020) Authors: Dummer, R.; Guminksi, A.; Gutzmer, R.; Lear, J.T.; Lewis, K.D.; Chang, A.L.S.; Combemale, P.; Dirix, L.; Kaatz, M.; Kudchadkar, R.; Loquai, C.; Plummer, R.; Schulze, H.‐J.; Stratigos, A.J.; Trefzer, U.; Squittieri, N.; Migden, M.R. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study. (8th December 2019) Authors: Dummer, R.; Guminksi, A.; Gutzmer, R.; Lear, J.T.; Lewis, K.D.; Chang, A.L.S.; Combemale, P.; Dirix, L.; Kaatz, M.; Kudchadkar, R.; Loquai, C.; Plummer, R.; Schulze, H.‐J.; Stratigos, A.J.; Trefzer, U.; Squittieri, N.; Migden, M.R. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study. (6th November 2017) Authors: Lear, J.T.; Migden, M.R.; Lewis, K.D.; Chang, A.L.S.; Guminski, A.; Gutzmer, R.; Dirix, L.; Combemale, P.; Stratigos, A.; Plummer, R.; Castro, H.; Yi, T.; Mone, M.; Zhou, J.; Trefzer, U.; Kaatz, M.; Loquai, C.; Kudchadkar, R.; Sellami, D.; Dummer, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 3(2018) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗